Notice: This CMS-approved document has been submitted - Philips ...
Notice: This CMS-approved document has been submitted - Philips ... Notice: This CMS-approved document has been submitted - Philips ...
CMS-1403-FC supplier. Our longstanding policy of having an anti-markup payment limitation on purchased TCs was codified in §414.50, and retained in the CY 2008 PFS final rule with comment period. (Similarly, we imposed an anti-markup payment limitation on purchased PCs in the CY 2008 PFS final rule with comment period and we proposed in the CY 2009 PFS proposed rule to retain status as a purchased PC as a separate basis imposing an anti-markup payment limitation.) Based on our decision to adopt Alternative 1 and to allow arrangements that do not meet the requirements of Alternative 1 to nevertheless avoid the anti-markup payment limitation if diagnostic testing services meet the requirements of Alternative 2, we believe that it is not necessary, and unduly complex, to use purchased tests and purchased interpretations as separate bases for imposing an anti-markup payment limitation. We provide a fuller explanation below, at section N.2.h., for deleting from §414.50 references to TCs and PCs purchased from an “outside supplier.” We are not creating an exception for tests ordered by a physician in a physician organization with no physician owners who have the right to receive profit distributions. By finalizing both proposed alternatives, we believe that our concern that the Alternative 2 approach could 428
CMS-1403-FC disadvantage nonproblematic arrangements involving nonprofit multi-specialty groups that have campus-based treatment facilities (and thus do not perform diagnostic testing in the same building as where patients are seen) largely becomes moot, as most such arrangements should be able to be structured to fit into Alternative 1, or failing that, Alternative 2. With respect to our specific solicitations of comments, we are not revising the meaning of “net charge” at this time. Moreover, we are not requiring at this time direct billing instead of permitting reassignment under certain circumstances; however, we may propose to do so in a future notice of proposed rulemaking. We considered the various recommendations commenters offered for the effective date for our revisions. We have decided to not deviate from the effective date that is generally applicable to this final rule with comment period and, thus, the revisions to §414.50 will become effective on January 1, 2009. Finally, we did not propose to make changes to the in- office ancillary services exception and are not making any changes to that exception in this final rule; however, we are aware of the commenters’ concerns and may propose rulemaking on this issue in the future. 429
- Page 377 and 378: CMS-1403-FC Therefore, we proposed
- Page 379 and 380: CMS-1403-FC Therefore, we proposed
- Page 381 and 382: CMS-1403-FC The following is a summ
- Page 383 and 384: CMS-1403-FC We are not making any c
- Page 385 and 386: CMS-1403-FC N. Physician Self-Refer
- Page 387 and 388: CMS-1403-FC arrangements, and the l
- Page 389 and 390: CMS-1403-FC below are related to ea
- Page 391 and 392: CMS-1403-FC clinical practice. With
- Page 393 and 394: CMS-1403-FC In the CY 2009 PFS prop
- Page 395 and 396: CMS-1403-FC would be outside the sc
- Page 397 and 398: CMS-1403-FC reflect objective quali
- Page 399 and 400: CMS-1403-FC quality resulting from
- Page 401 and 402: CMS-1403-FC payments should be reas
- Page 403 and 404: CMS-1403-FC changes in referral pat
- Page 405 and 406: CMS-1403-FC the alternative, we pro
- Page 407 and 408: CMS-1403-FC finalize this condition
- Page 409 and 410: CMS-1403-FC and “quality maintena
- Page 411 and 412: CMS-1403-FC date. We seek comments
- Page 413 and 414: CMS-1403-FC existing exceptions to
- Page 415 and 416: CMS-1403-FC our general rulemaking
- Page 417 and 418: CMS-1403-FC these approaches. We pr
- Page 419 and 420: CMS-1403-FC building in which the b
- Page 421 and 422: CMS-1403-FC were concerned that thi
- Page 423 and 424: CMS-1403-FC supplier will be subjec
- Page 425 and 426: CMS-1403-FC numerical test for the
- Page 427: CMS-1403-FC space in which the orde
- Page 431 and 432: CMS-1403-FC would be simpler to not
- Page 433 and 434: CMS-1403-FC IDTF standards in §410
- Page 435 and 436: CMS-1403-FC that rule, the Governme
- Page 437 and 438: CMS-1403-FC with comment period, th
- Page 439 and 440: CMS-1403-FC 1842(n)(1) of the Act,
- Page 441 and 442: CMS-1403-FC anti-markup provisions
- Page 443 and 444: CMS-1403-FC her group practice woul
- Page 445 and 446: CMS-1403-FC A commenter representin
- Page 447 and 448: CMS-1403-FC tenens arrangements cou
- Page 449 and 450: CMS-1403-FC other supplier. We are
- Page 451 and 452: CMS-1403-FC on pathology reports or
- Page 453 and 454: CMS-1403-FC patients. According to
- Page 455 and 456: CMS-1403-FC from sharing a practice
- Page 457 and 458: CMS-1403-FC Group A orders the TC a
- Page 459 and 460: CMS-1403-FC physicians the flexibil
- Page 461 and 462: CMS-1403-FC Response: We recognize
- Page 463 and 464: CMS-1403-FC Response: Because the d
- Page 465 and 466: CMS-1403-FC limited by the proposed
- Page 467 and 468: CMS-1403-FC Response: With respect
- Page 469 and 470: CMS-1403-FC to focus on the medical
- Page 471 and 472: CMS-1403-FC service” approach bec
- Page 473 and 474: CMS-1403-FC have the right to recei
- Page 475 and 476: CMS-1403-FC 2 approach finalized he
- Page 477 and 478: CMS-1403-FC the ordering physician
<strong>CMS</strong>-1403-FC<br />
supplier. Our longstanding policy of having an anti-markup<br />
payment limitation on purc<strong>has</strong>ed TCs was codified in<br />
§414.50, and retained in the CY 2008 PFS final rule with<br />
comment period. (Similarly, we imposed an anti-markup<br />
payment limitation on purc<strong>has</strong>ed PCs in the CY 2008 PFS<br />
final rule with comment period and we proposed in the CY<br />
2009 PFS proposed rule to retain status as a purc<strong>has</strong>ed PC<br />
as a separate basis imposing an anti-markup payment<br />
limitation.) Based on our decision to adopt Alternative 1<br />
and to allow arrangements that do not meet the requirements<br />
of Alternative 1 to nevertheless avoid the anti-markup<br />
payment limitation if diagnostic testing services meet the<br />
requirements of Alternative 2, we believe that it is not<br />
necessary, and unduly complex, to use purc<strong>has</strong>ed tests and<br />
purc<strong>has</strong>ed interpretations as separate bases for imposing an<br />
anti-markup payment limitation. We provide a fuller<br />
explanation below, at section N.2.h., for deleting from<br />
§414.50 references to TCs and PCs purc<strong>has</strong>ed from an<br />
“outside supplier.”<br />
We are not creating an exception for tests ordered by<br />
a physician in a physician organization with no physician<br />
owners who have the right to receive profit distributions.<br />
By finalizing both proposed alternatives, we believe that<br />
our concern that the Alternative 2 approach could<br />
428